# K110840: LIAC

- Pathway: 510(k) (Abbreviated)
- Applicant: Sordina S.P.A.
- Decided: Apr 17, 2012 after 389 days
- Product code: IYE (Accelerator, Linear, Medical)
- Device class: 2
- Regulation: 21 CFR 892.5050
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Most influential descendants
- K172961: Liac HWL (2018), 1 descendant of its own
- K182374: LIAC S (2019), 0 descendants of its own

## Indications for use
Liac (Models: 10MeV and 12MeV) is a mobile electron linear accelerator for intra-operative radiotherapy (lORT ), Known as intraoperative radiation therapy (IORT), this technique allows delivery of high doses cif radiation directly aimed at tumnors or other sites. The LIAC is meant to be used for radiotherapy in the operating theatre on a patient to which the surgeon has just removed a neoplasm. The device must be sold by or on the order of a physician. It is not for use by the general public or over-the-counter.

Source page: https://510kreport.com/device/K110840
Methodology: https://510kreport.com/methodology